sever
small
anim
model
develop
studi
sever
acut
respiratori
syndrom
coronaviru
sarscov
replic
pathogenesi
syrian
golden
hamster
among
best
small
anim
model
though
littl
clinic
ill
mortal
observ
viru
infect
cyclophosphamid
use
immunosuppress
hamster
lead
prolong
diseas
cours
higher
mortal
sarscov
infect
addit
signific
weight
loss
expand
tissu
tropism
increas
viral
patholog
lung
heart
kidney
nasal
turbin
tissu
infect
recombin
sarscov
virus
bear
disrupt
gene
code
region
show
signific
chang
replic
kinet
tissu
tropism
morbid
mortal
suggest
protein
requir
viru
replic
immunosuppress
hamster
modifi
hamster
model
may
provid
use
tool
sarscov
pathogenesi
studi
evalu
antivir
therapi
analysi
addit
sarscov
mutant
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
caus
agent
sever
atyp
pneumonia
novemb
diseas
first
appear
guangdong
provinc
southeast
china
rapidli
spread
hong
kong
taiwan
singapor
countri
six
contin
end
epidem
case
report
overal
mortal
rate
approxim
cdc
although
precis
origin
viru
elucid
evid
suggest
viru
like
transmit
bat
china
intermedi
host
mask
palm
civet
human
lau
et
al
li
et
al
ren
et
al
predomin
mechan
transmiss
via
airborn
droplet
although
isol
viru
fece
urin
may
suggest
addit
rout
transmiss
chan
et
al
poon
et
al
follow
inocul
viru
undergo
incub
period
day
chan
et
al
patient
subsequ
present
flulik
symptom
fever
malais
nonproduct
cough
progress
respiratori
deterior
typic
involv
lung
gu
korteweg
patient
often
present
wateri
diarrhea
hepat
dysfunct
patient
develop
respiratori
failur
requir
mechan
ventil
mortal
patient
year
age
approxim
howev
diseas
sever
significantli
increas
elderli
popul
mortal
rate
among
individu
year
age
approach
like
due
ineffect
antivir
immun
respons
diseas
sever
shown
correl
earli
onset
neutral
antibodi
respons
presenc
neutral
antibodi
within
first
two
week
ill
associ
increas
risk
mortal
ho
et
al
zhang
et
al
recov
patient
continu
increas
serum
neutral
antibodi
concentr
peak
approxim
day
wherea
fatal
case
demonstr
dramat
reduc
neutral
antibodi
day
symptom
onset
suggest
sustain
level
neutral
antibodi
correl
recoveri
sarscovinfect
patient
sinc
identif
viru
caus
sar
numer
anim
model
describ
attempt
evalu
viru
replic
pathogenesi
immunopatholog
anim
model
describ
date
includ
sever
inbr
mous
strain
hamster
civet
cat
ferret
cat
nonhuman
primat
glass
et
al
greenough
et
al
hogan
et
al
lawler
et
al
martina
et
al
mcauliff
et
al
qin
et
al
robert
et
al
row
et
al
subbarao
et
al
ter
meulen
et
al
wu
et
al
timecours
viru
replic
small
anim
model
significantli
rapid
observ
human
infect
robert
et
al
model
fulli
reproduc
clinic
ill
patholog
observ
human
need
exist
use
small
anim
model
close
mimic
human
diseas
sarscov
infect
syrian
golden
hamster
lead
viral
replic
lung
nasal
turbin
transient
viremia
extrapulmonari
replic
spleen
liver
robert
et
al
primari
hamster
tracheobronchi
epitheli
cell
cultur
support
higher
viru
replic
comparison
similar
murin
cultur
suggest
increas
suscept
hamster
cell
sarscov
infect
histopatholog
evid
diseas
evid
hamster
tissu
cellular
necrosi
pronounc
interstiti
inflamm
focal
consolid
pulmonari
tissu
loss
ciliat
epitheli
cell
promin
featur
robert
et
al
howev
limit
morbid
mortal
associ
infect
increas
sever
diseas
hamster
model
may
provid
use
tool
studi
sarscov
pathogenesi
antivir
drug
test
analysi
mutant
virus
delet
one
eight
viral
accessori
gene
report
cyclophosphamid
cp
induc
immunosuppress
syrian
golden
hamster
model
sarscov
infect
cyclophosphamid
bifunct
alkyl
agent
shown
caus
lymphopenia
suppress
bcell
activ
activ
suppress
regulatori
tcell
function
cupp
et
al
ikezawa
et
al
polak
turk
zhu
et
al
cp
util
variou
anim
model
viru
infect
analysi
often
increas
morbid
mortal
observ
virusinfect
anim
blandford
charlton
genovesi
peter
kercher
mitchel
kong
et
al
mateo
et
al
sidwel
et
al
smee
et
al
recent
cpinduc
immunosuppress
syrian
golden
hamster
shown
enhanc
adenoviru
replic
patholog
permit
efficaci
test
broadspectrum
antivir
toth
et
al
treatment
hamster
cp
augment
virusinduc
patholog
replic
recombin
sarscov
rsarscov
tissu
includ
lung
spleen
liver
kidney
heart
infect
anim
display
high
morbid
mortal
approxim
day
manner
depend
dosag
regimen
cp
similar
infect
pathogenesi
pattern
observ
infect
rsarscov
mutant
defect
express
accessori
protein
suggest
function
protein
requir
model
therefor
propos
infect
cptreat
hamster
rigor
test
vivo
viru
replic
virul
provid
exist
anim
model
examin
effect
cp
sever
rsarscov
diseas
hamster
group
anim
assign
either
salin
one
four
differ
cp
regimen
tabl
four
regimen
util
determin
doseand
timedepend
effect
cp
treatment
sever
diseas
anim
given
load
dose
follow
mainten
dose
specifi
interv
maintain
immunosuppress
monitor
effect
treatment
total
white
blood
cell
count
measur
blood
mock
infect
anim
rsarscov
infect
anim
treat
salin
cpa
cpd
prior
infect
variou
time
studi
fig
b
decreas
white
blood
cell
count
anim
treat
cp
confirm
immunosuppress
activ
treatment
regimen
anim
infect
intranas
tcid
rsarscov
rsarscov
viru
encod
gfp
place
gene
open
read
frame
rsarscov
viru
encod
delet
gene
open
read
frame
day
schaecher
et
al
yount
et
al
salinetr
anim
demonstr
elev
total
wbc
count
lymphocytosi
peak
day
postinfect
pi
return
near
baselin
level
day
pi
fig
treatment
mild
cp
regimen
cpa
result
signific
immunosuppress
anim
demonstr
lower
initi
wbc
count
viru
infect
compar
salin
treat
anim
fig
anim
treat
cpd
depress
total
wbc
count
day
compar
salinetr
anim
mean
wbc
count
wbcmm
respect
fig
day
pi
mean
wbc
count
cpd
treat
anim
drop
wbcmm
compar
near
baselin
level
wbcmm
salinetr
anim
confirm
immunosuppress
analyz
adapt
immun
respons
rsarscov
serum
neutral
antibodi
specif
sarscov
quantifi
day
pi
fig
use
viru
neutral
assay
salinetr
anim
develop
high
neutral
antibodi
titer
day
pi
signific
differ
observ
anim
infect
differ
rsarscov
virus
contrast
littl
neutral
antibodi
detect
cpd
treat
anim
day
pi
day
pi
anim
treat
cpa
detect
neutral
antibodi
respons
virus
howev
mean
neutral
titer
lower
observ
salinetr
anim
respect
neutral
antibodi
detect
uninfect
anim
virusinfect
anim
treat
cpb
anim
treat
regimen
cpc
analyz
neutral
antibodi
titer
anim
monitor
morbid
mortal
fig
cours
approxim
day
mock
infect
anim
treat
cp
regimen
demonstr
signific
weight
loss
overt
clinic
ill
compar
salinetr
uninfect
hamster
fig
except
two
six
cpd
treat
anim
mortal
observ
fig
indic
cp
treatment
less
day
littl
impact
viabil
observ
previous
robert
et
al
schaecher
et
al
sarscov
infect
hamster
result
minim
clinic
ill
transient
weight
loss
day
pi
fig
e
g
mortal
observ
salinetr
hamster
black
line
infect
viru
viru
infect
cpa
treat
anim
yellow
line
result
modest
weight
loss
coupl
modest
clinic
symptom
fur
ruffl
decreas
activ
compar
virusinfect
salinetr
hamster
result
increas
mortal
contrast
infect
cpb
green
line
cpc
blue
line
cpd
red
line
treat
anim
result
increas
weight
loss
mortal
two
cpb
treat
infect
anim
surviv
beyond
day
demonstr
clinic
improv
weight
gain
infect
anim
treat
cpc
cpd
progress
lost
weight
throughout
approxim
day
statist
signific
differ
weight
loss
observ
among
treatment
group
infect
virus
bear
disrupt
accessori
gene
led
morbid
mortal
similar
seen
wildtyp
viru
indic
disrupt
gene
significantli
alter
virul
anim
model
tissu
analyz
variou
time
pi
viru
titer
lung
salin
cpa
treat
anim
contain
high
viru
titer
earli
day
pi
titer
remain
high
day
data
shown
day
pi
salinetr
anim
clear
detect
viru
lung
tissu
two
three
cpa
treat
anim
continu
high
lung
viral
titer
day
pi
extrapulmonari
viru
detect
tcid
analysi
salinetr
anim
viru
titer
detect
sever
liver
tissu
harvest
cpa
treat
infect
anim
day
pi
data
shown
viru
detect
tissu
cpa
treat
anim
tissu
cpb
treat
anim
analyz
day
pi
fig
lung
titer
salin
cpb
treat
anim
high
day
viru
detect
lung
salinetr
anim
day
pi
howev
cpb
treat
anim
unabl
clear
viru
lung
titer
remain
high
day
progress
increas
viru
titer
detect
liver
spleen
cpb
treat
anim
salinetr
anim
high
viru
titer
present
lung
liver
spleen
kidney
tissu
day
pi
cpd
treat
anim
viru
detect
salinetr
anim
fig
presenc
viru
titer
kidney
tissu
signific
sarscov
detect
moribund
anim
sacrif
along
uninfect
cpd
agematch
salinetr
anim
viru
titer
determin
heart
tissu
panel
viru
titer
n
anim
determin
tcid
assay
present
mean
standard
error
kidney
urin
patient
gu
korteweg
xu
et
al
signific
differ
viru
titer
observ
wildtyp
delet
virus
salin
cpd
treat
anim
tissu
harvest
moribund
anim
treat
cpb
cpc
cpd
reveal
high
viru
titer
lung
liver
spleen
kidney
fig
three
treatment
allow
equival
level
viru
replic
signific
differ
observ
rsarscov
rsarscov
respect
infecti
viru
titer
lung
liver
kidney
tissu
p
n
rsarscov
virusinfect
hamster
appear
higher
viru
titer
spleen
differ
statist
signific
p
final
heart
tissu
analyz
viral
titer
salinetr
moribund
cpd
treat
anim
infect
rsarscov
fig
viru
detect
heart
salinetr
infect
anim
howev
high
viral
titer
observ
heart
tissu
cpd
treat
anim
although
tissu
specif
express
cellular
receptor
sarscov
determin
hamster
express
heart
kidney
test
human
donoghu
et
al
tipni
et
al
high
viral
titer
heart
anim
suggest
also
present
heart
tissu
hamster
note
heart
patholog
also
observ
human
tissu
fatal
sar
case
includ
cardiac
edema
atrophi
myocardi
fiber
chong
et
al
ding
et
al
gu
et
al
lang
et
al
summari
histopatholog
due
cp
treatment
shown
tabl
day
pi
administr
cp
alon
cpd
conjunct
viru
challeng
associ
mild
mark
hematopoiet
atrophi
bone
marrow
femur
sternum
mild
moder
lymphoid
deplet
mandibular
andor
mesenter
lymph
node
moder
mark
lymphoid
deplet
spleen
mild
moder
follicular
atresia
ovari
wellknown
consequ
cp
administr
rodent
jarrel
et
al
atrophi
hematopoiet
lymphoid
tissu
consist
chemotherapeut
immunosuppress
pharmacolog
cp
hematopoiet
atrophi
also
evid
bone
marrow
cpd
treat
infect
anim
day
pi
evid
day
pi
two
instanc
necrot
vagin
observ
hamster
treat
regimen
cpd
one
virusinfect
one
sinc
incid
find
low
definit
relationship
cp
administr
certain
howev
find
consist
opportunist
bacteri
infect
follow
immunosuppress
cp
histopatholog
find
salinetr
rsarscov
infect
anim
gener
consist
previous
describ
sacrif
ed
viru
robert
et
al
rsarscov
infect
cpd
treat
anim
result
increas
sever
histopatholog
find
pulmonari
extrapulmonari
tissu
summar
tabl
day
pi
chronic
bronchointerstiti
pneumonia
mild
moder
sever
observ
hamster
infect
rsarscov
follow
immunosuppress
cp
fig
panel
iii
lesion
character
presenc
multifoc
infiltr
mix
popul
macrophag
neutrophil
lesser
number
lymphocyt
plasma
cell
area
fibrosi
hyperplasia
alveolar
epitheli
cell
frequent
observ
infiltr
center
junction
distal
bronchiol
alveoli
day
pi
chang
present
untreat
rsarscov
infect
anim
tabl
examin
lung
anim
given
rsarscov
cp
earlier
time
pi
reveal
presenc
moder
subacut
bronchointerstiti
pneumonia
one
two
anim
sacrif
day
pi
tabl
fig
panel
ii
meaning
chang
present
day
pi
histolog
lesion
similar
day
lesion
distribut
lack
conspicu
fibrosi
instead
hyperplasia
alveolar
epitheli
cell
promin
featur
earlier
time
point
similar
microscop
chang
also
present
lung
rsarscov
infect
anim
treat
cp
day
tabl
lesion
observ
day
pi
subacut
inflamm
minim
sever
record
mani
anim
treatment
group
although
chang
observ
small
day
control
group
similar
find
extrem
common
lung
hamster
age
therefor
chang
consid
repres
consequ
either
rsarscov
cp
administr
day
pi
multifoc
subacut
myocardi
inflamm
minim
sever
present
heart
two
anim
given
rsarscov
cp
salinetr
infect
anim
fig
tabl
chang
consist
infiltr
mix
popul
neutrophil
lymphocyt
macrophag
occasion
surround
degener
necrot
cardiac
myocyt
fig
similar
chang
observ
heart
anim
earlier
sacrific
interv
fibrinopurul
exud
visibl
adher
mucos
surfac
multipl
level
nasal
caviti
anim
inocul
rsarscov
day
pi
tabl
signific
inflammatori
cell
infiltr
within
submucosa
nasal
turbin
mild
degener
olfactori
epithelium
present
region
chang
present
cp
salinetr
group
day
observ
cptreat
anim
day
pi
fig
dilat
renal
cortic
tubul
tubular
degener
necrosi
present
kidney
infect
cpd
treat
anim
sacrif
day
pi
anim
given
cp
tabl
chang
mild
sever
affect
one
two
anim
histolog
chang
note
gastrointestin
tract
brain
therefor
tissu
analyz
subsequ
experi
base
upon
initi
observ
target
organ
virusassoci
histopatholog
consid
lung
heart
nasal
turbin
kidney
determin
signific
find
morbid
mortal
rsarscov
infect
immunosuppress
hamster
followup
studi
conduct
four
anim
immunosuppress
use
cpd
regimen
inocul
tcid
rsarscov
four
anim
given
cp
salin
use
control
anim
care
monitor
evid
moribund
mortal
observ
match
number
control
anim
sacrif
comparison
anim
follow
tissu
examin
microscop
heart
lung
spleen
kidney
bone
marrow
nasal
turbin
tabl
one
rsarscov
infect
cp
immunosuppress
anim
found
dead
day
pi
tissu
anim
exhibit
chang
compar
describ
howev
anim
also
mark
focal
myocardi
infarct
necrosi
bacteria
consist
septic
myocardi
infarct
septicem
cardiac
diseas
interpret
caus
death
anim
like
secondari
immunosuppress
cp
initi
studi
cp
treatment
presenc
absenc
viral
inocul
associ
hematopoiet
atrophi
bone
marrow
lymphoid
deplet
spleen
rsarscov
infect
hamster
inflammatori
chang
similar
describ
heart
present
anim
tabl
histolog
inflammatori
chang
sever
observ
day
pi
three
anim
surviv
day
pi
sever
pulmonari
lesion
observ
repres
increas
consolid
histolog
sever
lesion
observ
day
pi
extens
pulmonari
hemorrhag
edema
lung
anim
tabl
rsarscov
infect
anim
exhibit
minim
moder
renal
tubular
degener
necrosi
fibrinopurul
exud
within
nasal
turbin
similar
describ
tabl
lack
small
anim
model
close
resembl
human
sarscov
infect
restrict
studi
sarscov
pathogenesi
vaccin
design
analysi
antivir
therapi
vivo
patholog
analysi
respiratori
tract
sar
patient
reveal
diffus
alveolar
damag
hyalin
membran
format
interstiti
edema
extrapulmonari
patholog
includ
splenic
lymphocyt
deplet
atrophi
acut
tubular
necrosi
kidney
neuron
edema
degener
heart
edema
myocardi
fiber
atrophi
minor
patholog
chang
bone
marrow
skelet
muscl
adren
thyroid
gland
test
review
gu
korteweg
viral
particl
viral
genom
detect
numer
tissu
cell
type
includ
respiratori
epithelium
circul
lymphocyt
monocyt
lymphoid
tissu
intestin
mucos
epithelium
renal
distal
tubul
epitheli
cell
neuron
brain
macrophag
multipl
organ
ideal
small
anim
model
would
encompass
mani
characterist
human
infect
includ
sever
pulmonari
diseas
spread
viru
extrapulmonari
organ
tissu
histopatholog
reminisc
human
infect
overt
clinic
symptom
longer
time
period
infect
mortal
balbc
mice
predominantli
util
small
anim
infect
studi
sarscov
inocul
mous
strain
demonstr
moder
replic
nasal
turbin
lung
howev
peak
titer
occur
day
pi
viru
clear
day
pi
glass
et
al
hogan
et
al
robert
et
al
subbarao
et
al
infect
mice
display
overt
clinic
diseas
demonstr
morbid
mortal
age
balbc
mous
model
describ
demonstr
observ
morbid
includ
weight
loss
ruffl
fur
increas
histopatholog
find
robert
et
al
mortal
observ
mice
analyz
potenti
anim
model
display
prolong
infect
period
extrapulmonari
spread
liver
spleen
histopatholog
find
acut
interstiti
pneumonia
hogan
et
al
although
mortal
report
first
murin
model
demonstr
sever
diseas
mortal
util
mice
transgen
human
sarscov
cellular
receptor
mccray
et
al
tseng
et
al
infect
transgen
mice
result
sever
rapid
progress
diseas
mortal
day
pi
viru
replic
detect
sever
organ
high
viru
titer
brain
day
although
potenti
use
pathogenesi
studi
sever
rapid
natur
diseas
coupl
promin
neurolog
involv
may
constrain
use
small
anim
model
sarscov
addit
mouseadapt
strain
sarscov
gener
via
serial
passag
balbc
mice
robert
et
al
viru
capabl
caus
sever
diseas
mice
extrapulmonari
spread
howev
transgen
mice
diseas
rapid
caus
death
within
day
inocul
result
studi
demonstr
cpinduc
immunosuppress
syrian
golden
hamster
significantli
increas
sever
sarscov
diseas
although
hamster
permiss
sarscov
infect
anim
demonstr
minim
clinic
ill
weight
loss
mortal
observ
robert
et
al
use
cp
induc
immunosuppress
state
result
signific
increas
viral
patholog
increas
weight
loss
expand
tissu
tropism
prolong
time
frame
diseas
low
dose
cp
regimen
cpa
led
prolong
viru
replic
lung
organ
moder
weight
loss
mortal
sinc
effect
cp
primarili
lymphoid
cell
popul
data
suggest
involv
cell
type
control
clearanc
sarscov
lung
increas
cp
dose
frequenc
result
signific
increas
patholog
mortal
cpb
treatment
result
mortal
rate
wherea
cpc
cpd
infect
anim
die
within
approxim
day
rsarscov
infect
high
viru
titer
observ
numer
tissu
cpb
cpc
cpd
treat
anim
includ
lung
liver
spleen
kidney
heart
infect
rsarscov
associ
acut
fibrinopurul
exud
nasal
caviti
renal
tubular
degener
necrosi
regardless
presenc
absenc
cp
immunosuppress
addit
rsarscov
infect
follow
cpd
immunosuppress
produc
bronchointerstiti
pneumonia
progress
sever
durat
experi
subacut
inflamm
ventricular
myocardium
observ
immunosuppress
rsarscov
infect
anim
increas
sever
observ
day
pi
latter
chang
chronic
bronchointerstiti
pneumonia
myocardi
inflamm
like
contribut
sever
clinic
diseas
necessit
sacrific
moribund
anim
day
pi
import
note
see
patholog
gastrointestin
tract
brain
sarscov
infect
hamster
sarscov
associ
gastrointestin
tissu
human
autopsi
mice
express
human
receptor
show
symptom
enceph
sarscov
infect
signific
sarscov
infectin
brain
gastrointestin
tract
clear
remain
open
area
investig
although
immunosuppress
model
like
use
vaccin
studi
may
signific
util
analysi
virul
recombin
virus
assess
efficaci
antivir
compound
treatment
studi
analyz
vivo
replic
pathogenesi
two
recombin
sarscov
strain
delet
region
rsarscov
virus
replic
wildtyp
effici
vitro
mous
model
sarscov
infect
dediego
et
al
schaecher
et
al
sim
et
al
yount
et
al
togeth
data
suggest
sarscov
protein
requir
viral
replic
small
anim
model
describ
date
may
provid
luxuri
function
host
speci
import
test
number
recombin
virus
bear
disrupt
accessori
gene
immunosuppress
hamster
model
clear
increas
patholog
observ
cptreat
infect
anim
due
increas
viru
replic
prolong
viru
replic
increas
damag
cytokin
induc
infect
reagent
cytokin
analysi
hamster
lack
clearli
import
area
futur
research
efficaci
antivir
immunotherapi
protect
cptreat
hamster
sarscov
diseas
import
assess
increas
viru
replic
spread
viru
extrapulmonari
site
provid
rigor
test
treatment
efficaci
recombin
sarscov
kindli
provid
ralph
baric
univers
north
carolina
either
recombin
wildtyp
sarscov
rsarscov
viru
gfp
place
gene
code
region
rsarscov
viru
gene
region
fulli
delet
rsarscov
use
briefli
nucleotid
access
number
either
delet
replac
orf
gfp
recombin
virus
gener
previous
describ
yount
et
al
virus
propag
viru
titer
determin
previous
describ
nelson
et
al
schaecher
et
al
infect
perform
biosafeti
level
laboratori
use
institut
biosafeti
committe
approv
procedur
six
seven
weekold
syrian
golden
hamster
charl
river
laboratori
hous
three
per
cage
biosafeti
level
anim
facil
cp
sigma
dissolv
salin
vigor
shake
make
stock
solut
mgml
anim
inject
ip
ml
salin
ml
cp
desir
concentr
per
dose
schedul
detail
tabl
maintain
immunosuppress
anim
acclimat
biosafeti
contain
rack
least
day
inocul
pb
tcid
viru
total
volum
nari
hamster
weigh
indic
time
pi
cpinduc
immunosuppress
monitor
total
white
blood
cell
wbc
count
util
use
pentra
hematolog
analyz
abx
diagnost
montpelli
franc
per
manufactur
protocol
sampl
collect
viru
infect
manual
differenti
cell
count
also
perform
sampl
collect
viru
infect
use
blood
smear
modifi
wright
stain
ten
field
cell
count
magnif
per
sampl
hamster
sacrif
indic
day
pi
viru
titer
homogen
lung
kidney
liver
spleen
heart
tissu
determin
row
et
al
tissu
weigh
complet
medium
ad
achiev
weight
volum
wtvol
suspens
homogen
use
tissu
grinder
fisher
centrifug
rpm
min
supernat
remov
analyz
tcid
assay
procedur
perform
protocol
approv
institut
biosafeti
institut
anim
care
use
committe
anim
sera
collect
infect
anim
day
pi
assay
presenc
antisarscov
neutral
antibodi
essenti
describ
other
briefli
serum
heat
inactiv
min
twofold
dilut
inactiv
sera
mix
complet
media
final
volum
per
well
tcid
sarscov
per
seracontain
media
ad
antiseraviru
suspens
preincub
min
ad
well
vero
cell
monolay
well
plate
per
serum
dilut
cell
fix
formaldehyd
day
pi
stain
napthol
blueblack
sigma
analyz
cytopath
effect
dilut
serum
prevent
cytopath
effect
well
calcul
use
reedmuench
formula
reed
muench
formalinfix
tissu
embed
paraffin
thick
section
gener
microtom
stain
hematoxylin
eosin
cpd
treatment
regimen
use
histopatholog
studi
follow
tissu
harvest
day
pi
adren
gland
aorta
bone
femur
bone
sternum
bone
marrow
femur
bone
marrow
sternum
brain
cecum
cervix
colon
duodenum
esophagu
eye
gall
bladder
harderian
gland
heart
ileum
jejunum
kidney
larynx
liver
lung
mammari
gland
mandibular
lymph
node
mesenter
lymph
node
nasal
caviti
level
optic
nerv
ovari
pancrea
parathyroid
pituitari
gland
rectum
salivari
gland
skelet
muscl
skin
spinal
cord
spleen
stomach
thymu
thyroid
tongu
trachea
urinari
bladder
uteru
vagina
tissu
two
anim
per
condit
assess
base
find
full
survey
tissu
tissu
includ
bone
marrow
sternum
tibia
heart
lung
kidney
spleen
nasal
caviti
anim
per
group
examin
indic
day
postinfect
subsequ
experi
